Titre : | Dual diagnosis screening: preliminary findings on the comparison of 50 clients attending community mental health services and 50 clients attending community substance misuse services (2002) |
Titre traduit : | (Dépistage d'un double diagnostic : découvertes préliminaires à partir d'une comparaison de 50 patients relevant des services psychiatriques et 50 autres relevant des services spécialisés en toxicomanie) |
Auteurs : | V. C. MANNING ; G. STRATHDEE ; D. BEST ; F. KEANEY ; McGILLIVRAY L. ; J. WITTON |
Type de document : | Article : Périodique |
Dans : | Journal of Substance Use (Vol.7, n°4, 2002) |
Article en page(s) : | 221-228 |
Note générale : |
Journal of Substance Use, 2002, 7, (4), 221-228 |
Langues: | Anglais |
Mots-clés : |
Thésaurus mots-clés COMORBIDITE ; DIAGNOSTIC ; HOPITAL ; CSST ; DEPISTAGE ; TEST ; ENQUETE ; PSYCHOPATHOLOGIE ; POLYCONSOMMATIONThésaurus géographique ROYAUME-UNI |
Résumé : |
ENGLISH : While dual diagnosis research has often focussed on substance misuse disorders among mental health clients, relatively little is known about comparable rates of dual diagnosis in community mental health and substance misuse settings because of, inter alia, limitations and lack of consistency in screening. In the current study clinicians administered a brief screening tool, which detects problematic alcohol, drug use, psychosis and common mental health symptoms, to 50 substance misuse and 50 mental health treatment attenders. Sixty-four per cent of the total sample screened positive for dual diagnosis (positive far any psychiatric disorder and either a drug or alcohol problem). Highest rates were observed in the alcohol sample (92.3%), followed by the drug sample (87.5%), and lowest in the community mental health (CMHT) sample (38%). Current depression and social phobia were most prevalent in alcohol clients compared to psychosis, mania and suicidal ideation in CMHT clients. Around one-third of CMHT clients reported using drugs (mainly cannabis) and around a fifth reported problematic alcohol use. The study demonstrates the feasibility of incorporating a dual diagnosis screen into routine clinical practice. The screen can be used in both mental health and substance misuse treatment settings, which are evidently managing complex client caseloads. (Review' s abstract) |
Note de contenu : | tabl. |
Domaine : | Drogues illicites / Illicit drugs |
Refs biblio. : | 34 |
Affiliation : |
National Addiction Ctre / Institute of Psychiatry, ASB, 4 Windsor Walk, Denmark Hill, London SE5 8AF Royaume-Uni. United Kingdom. |
Numéro Toxibase : | 1300404 |
Centre Emetteur : | 13 OFDT |
Cote : | Abonnement |
Accueil